{"title":"致编辑;评论“从发起人到生物仿制人生长激素的对话团队转换:来自瑞典的单中心经验”。","authors":"Mats Ekelund, Christopher Bidad, Roy Gomez","doi":"10.1007/s13554-014-0015-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":89899,"journal":{"name":"Biologics in therapy","volume":"4 1-2","pages":"69-71"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13554-014-0015-3","citationCount":"2","resultStr":"{\"title\":\"To the Editor; A Commentary on \\\"Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden\\\".\",\"authors\":\"Mats Ekelund, Christopher Bidad, Roy Gomez\",\"doi\":\"10.1007/s13554-014-0015-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":89899,\"journal\":{\"name\":\"Biologics in therapy\",\"volume\":\"4 1-2\",\"pages\":\"69-71\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s13554-014-0015-3\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biologics in therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13554-014-0015-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/4/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologics in therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13554-014-0015-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/4/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
To the Editor; A Commentary on "Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden".